{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:05:01Z","timestamp":1790222701444,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.diabet.2023.101444","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T15:17:29Z","timestamp":1680794249000},"page":"101444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis"],"prefix":"10.1016","volume":"49","author":[{"given":"Laurence","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Reix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mosnier-Pudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Ronsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Beltrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Stremler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Rakotoarisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Galderisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Perge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bendelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Abely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-5625","authenticated-orcid":false,"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2023.101444_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02288-2020","article-title":"Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study","volume":"58","author":"McKone","year":"2021","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.diabet.2023.101444_bib0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/M16-0858","article-title":"Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study","volume":"166","author":"Stephenson","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0003","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thorax-2022-219086","article-title":"Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand","volume":"78","author":"Coriati","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.diabet.2023.101444_bib0004","unstructured":"Registre fran\u00e7ais de la mucoviscidose https:\/\/www.vaincrelamuco.org\/sites\/default\/files\/registre_francais_de_la_mucoviscidose_bilan_2021.pdf"},{"key":"10.1016\/j.diabet.2023.101444_bib0005","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0007","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.201512-2518OC","article-title":"Abnormal glucose tolerance in infants and young children with cystic fibrosis","volume":"194","author":"Yi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0008","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.2337\/dc10-0613","article-title":"Impaired fasting glucose in cystic fibrosis","volume":"33","author":"Frohnert","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0009","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0011","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0012","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: a CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.10.009","article-title":"Cystic fibrosis related diabetes in Europe: prevalence, risk factors and outcome; Olesen","volume":"19","author":"Olesen","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0014","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0015","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc17-1387","article-title":"Islet interleukin-1beta immune reactivity is an early feature of cystic fibrosis that may contribute to beta-cell failure","volume":"41","author":"Hull","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0016","doi-asserted-by":"crossref","first-page":"17231","DOI":"10.1038\/s41598-017-17404-z","article-title":"Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes","volume":"7","author":"Bogdani","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabet.2023.101444_bib0017","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/dc16-0020","article-title":"Does \u03b2-cell autoimmunity play a role in cystic fibrosis-related diabetes? Analysis based on the German \/Austrian Diabetes Patient Registry","volume":"39","author":"Konrad","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0018","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.1002854","article-title":"IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction","volume":"187","author":"Westwell-Roper","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.diabet.2023.101444_bib0019","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1172\/JCI60610","article-title":"2012 Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets","volume":"122","author":"Olivier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2023.101444_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-12-87","article-title":"CFTR and anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells","volume":"12","author":"Edlund","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0021","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2023.101444_bib0022","doi-asserted-by":"crossref","first-page":"e98240","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis-related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.diabet.2023.101444_bib0023","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bbadis.2017.08.011","article-title":"Mechanisms of endothelial cell dysfunction in cystic fibrosis","volume":"1863","author":"Totani","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.diabet.2023.101444_bib0024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-213X-10-38","article-title":"Exocrine-to-endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas","volume":"10","author":"Kopinke","year":"2010","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.diabet.2023.101444_bib0025","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1210\/jc.2013-4417","article-title":"Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial","volume":"99","author":"Perano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0026","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1210\/en.2015-1935","article-title":"A transient metabolic recovery from early life glucose intolerance in cystic fibrosis ferrets occurs during pancreatic remodelling","volume":"157","author":"Yi","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabet.2023.101444_bib0027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0028","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","article-title":"Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European epidemiologic registry of cystic fibrosis","volume":"32","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.diabet.2023.101444_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0293-2020","article-title":"Cystic fibrosis-related diabetes and lung disease: an update","volume":"30","author":"Prentice","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.diabet.2023.101444_bib0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.10.009","article-title":"Cystic fibrosis related diabetes in Europe: prevalence, risk factors and outcome","volume":"19","author":"Olesen","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0031","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/ajrccm.162.3.9904075","article-title":"Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline","volume":"162","author":"Milla","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0033","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/jpem-2017-0005","article-title":"Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function","volume":"30","author":"Terliesner","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0034","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ppul.21127","article-title":"Growth in children with cystic fibrosis-related diabetes","volume":"44","author":"Cheung","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.diabet.2023.101444_bib0035","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/ppul.25572","article-title":"Nutritional status between 5 and 10 years is associated with cystic fibrosis-related diabetes in adolescence","volume":"56","author":"Ararat","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.diabet.2023.101444_bib0036","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ppul.23042","article-title":"Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis","volume":"50","author":"Bizzarri","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.diabet.2023.101444_bib0037","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcf.2019.08.011","article-title":"Cystic fibrosis related diabetes: nutrition and growth considerations","volume":"18","author":"Kaminski","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0038","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.diabet.2023.101444_bib0039","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ajcn\/75.6.1005","article-title":"Abnormal lipid concentrations in cystic fibrosis","volume":"75","author":"Figueroa","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabet.2023.101444_bib0041","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","article-title":"Microvascular complications in cystic fibrosis-related diabetes","volume":"30","author":"Schwarzenberg","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0042","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2023.101444_bib0043","article-title":"Gestational and pregestational diabetes in pregnant women with cystic fibrosis","volume":"27","author":"Oxman","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.diabet.2023.101444_bib0044","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13300-022-01223-1","article-title":"Cystic fibrosis-related diabetes mellitus and pregnancy: a retrospective study","volume":"13","author":"Davern","year":"2022","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabet.2023.101444_bib0045","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e31826d7eca","article-title":"Effect of maternal cystic fibrosis genotype on diabetes in pregnancy","volume":"120","author":"Giacobbe","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.diabet.2023.101444_bib0046","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcf.2020.09.002","article-title":"Baseline cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression","volume":"20","author":"Cohen-Cymberknoh","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0047","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2019.06.003","article-title":"Participating centers of the French cystic fibrosis registry. Pregnancy outcome in women with cystic fibrosis and poor pulmonary function","volume":"19","author":"Reynaud","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0048","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/aogs.13185","article-title":"Pregnancy outcome in women with cystic fibrosis-related diabetes","volume":"96","author":"Reynaud","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.diabet.2023.101444_bib0049","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0035-1547347","article-title":"Lung transplantation for cystic fibrosis: results, indications, complications, and controversies","volume":"36","author":"Lynch","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.diabet.2023.101444_bib0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1399-0012.2005.00420.x","article-title":"Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation","volume":"19","author":"Hadjiliadis","year":"2005","journal-title":"Clin Transp"},{"key":"10.1016\/j.diabet.2023.101444_bib0051","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.jcf.2019.08.019","article-title":"Endocrine complications after solid-organ transplant in cystic fibrosis","volume":"18","author":"Sidhaye","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0052","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0053","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","article-title":"Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor","volume":"73","author":"Bessonova","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.diabet.2023.101444_bib0054","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcf.2020.09.001","article-title":"Lumacaftor\/ivacaftor therapy fails to increase insulin secretion in F508del\/F508del CF patients","volume":"20","author":"Moheet","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcf.2020.03.002","article-title":"Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients","volume":"19","author":"Misgault","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0056","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0057","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcf.2006.08.004","article-title":"Cystic fibrosis related diabetes in an extremely young patient","volume":"6","author":"Casas","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0058","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jcf.2020.02.009","article-title":"Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis","volume":"19","author":"Prentice","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0059","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcf.2019.03.010","article-title":"Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis","volume":"18","author":"Prentice","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0\u00a0mmol\/L (54\u00a0mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0061","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcf.2016.02.012","article-title":"Hypoglycaemia in cystic fibrosis in the absence of diabetes: a systematic review","volume":"15","author":"Armaghanian","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0062","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/eje.1.02344","article-title":"Spontaneous hypoglycemia in patients with cystic fibrosis","volume":"156","author":"Battezzati","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2023.101444_bib0063","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcf.2018.03.009","article-title":"Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes","volume":"17","author":"Mannik","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0064","unstructured":"Cystic fibrosis foundation patient registry annual data report 2020"},{"key":"10.1016\/j.diabet.2023.101444_bib0065","article-title":"Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: a French survey from the 47 centers","volume":"28","author":"Weiss","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.diabet.2023.101444_bib0066","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2021.05.010","article-title":"HOMA indices as screening tests for cystic fibrosis-related diabetes","volume":"21","author":"Toin","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0067","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2008-0801","article-title":"Reproducibility of the oral glucose tolerance test in overweight children","volume":"93","author":"Libman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0068","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S2352-4642(17)30044-5","article-title":"Prediabetes in youth - mechanisms and biomarkers","volume":"1","author":"Weiss","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.diabet.2023.101444_bib0069","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/jpem-2016-0184","article-title":"Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?","volume":"30","author":"Mainguy","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc10-1604","article-title":"Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis","volume":"34","author":"Brodsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0071","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/278678","article-title":"The acute and residual effect of a single exercise session on meal glucose tolerance in sedentary young adults","volume":"2012","author":"Short","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0072","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11605-017-3376-3","article-title":"The effect of gastrostomy placement on gastric function in children: a prospective cohort study","volume":"21","author":"Franken","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.diabet.2023.101444_bib0073","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2015.03.001","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","volume":"15","author":"Coriati","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0074","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00125-021-05423-5","article-title":"Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis","volume":"64","author":"Bonhoure","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2023.101444_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112578","article-title":"High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening study","volume":"9","author":"Scheuing","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabet.2023.101444_bib0076","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jcf.2019.02.001","article-title":"How reliable is your HbA1c test? Revisiting the use of HbA1c in cystic fibrosis-related diabetes (CFRD) screening","volume":"18","author":"Lam","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0077","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcjd.2021.03.005","article-title":"Glycated hemoglobin as a first-line screening test for cystic fibrosis\u2012related diabetes and impaired glucose tolerance in children with cystic fibrosis: a validation study","volume":"45","author":"Racine","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0078","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0079","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"cystic fibrosis-related diabetes screening in adults: a gap analysis and evaluation of accuracy of glycated hemoglobin levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcjd.2018.11.005","article-title":"Validation of a stepwise approach using glycated hemoglobin levels to reduce the number of required oral glucose tolerance tests to screen for cystic fibrosis-related diabetes in adults","volume":"43","author":"Boudreau","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0081","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0082","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcf.2015.10.010","article-title":"HbA1c: an effective screening tool for cystic fibrosis related diabetes?","volume":"15","author":"Schnyder","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0083","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1210\/clinem\/dgab692","article-title":"The relationship between continuous glucose monitoring and OGTT in youth and young adults with cystic fibrosis","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0084","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2020.08.020","article-title":"Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index","volume":"20","author":"Tommerdahl","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0085","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1569-1993(21)01441-7","article-title":"Continuous glucose monitors in CFRD screening: what can they do?","volume":"20","author":"Kutney","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0086","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/db16-0394","article-title":"Reduced \u03b2-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance","volume":"66","author":"Sheikh","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2023.101444_bib0087","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/diacare.26.6.1940-a","article-title":"Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis","volume":"26","author":"Dobson","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2023.101444_bib0088","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/CS20030333","article-title":"Effect of hyperglycaemia on glucose concentration of human nasal secretions","volume":"106","author":"Wood","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabet.2023.101444_bib0089","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","article-title":"Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance","volume":"40","author":"Moreau","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabet.2023.101444_bib0091","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-1020","article-title":"Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system","volume":"162","author":"Schiaffini","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2023.101444_bib0092","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/archdischild-2017-314250","article-title":"Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis","volume":"103","author":"Zorr\u00f3n Mei Hsia","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.diabet.2023.101444_bib0093","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0094","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2021.01.002","article-title":"Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring","volume":"20","author":"Elidottir","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200\u2009mg\/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","volume":"2016","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabet.2023.101444_bib0096","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.diabet.2023.101444_bib0097","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/JPEM.2008.21.2.109","article-title":"Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis","volume":"21","author":"Franzese","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabet.2023.101444_bib0098","first-page":"576","article-title":"Carbohydrate metabolism impairment in children and adolescents with cystic fibrosis","volume":"69","author":"Garc\u00eda","year":"2022","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.diabet.2023.101444_bib0099","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/pedi.12914","article-title":"Screening for cystic fibrosis-related diabetes and prediabetes: evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c","volume":"20","author":"Tommerdahl","year":"2019","journal-title":"Pediatr Diabetes"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363623000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363623000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:59:06Z","timestamp":1761130746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363623000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1262363623000265"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2023.101444","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2023.101444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101444"}}